• Crystal Formulation Services Received China Drug Product Manufacturing License
• MilliporeSigma, InnoCore Announce Global Cooperation Agreement
• Aptuit Acquires Kuecept Ltd.
• InVitria Announces New Media Formulation Service
• Berkshire Sterile Names Dr. Xufeng Sun as Vice President of Formulation and Technology Transfer
• Destiny Pharma, MedPharm Complete Initial Phase of New XF-Platform Drug Formulations
• SeraNovo Announces Second License Agreement with Carna Biosciences
• Berkshire Sterile to Offer Formulation, Lyophilization, and Method Development Services
• ReForm Biologics Announces Issuance of U.S. Patent
• ReForm Biologics Announces Issuance of Patent for New Excipient

• Quotient Sciences Expands Formulation Development Capabilities to Further Accelerate Drug Development Timelines
• Mikart Acquires Korsch XM12 for Formulation Development & Production of Oral Solid Dose Products
• Aptuit Announces Enhancement of Integrated IND Enabling Services
• First Wave BioPharma Engages Rho to Manage Phase 2 Clinical Trial of Enhanced Adrulipase Formulation
• Metrics Expand Staff with New Formulation Scientist
• Sirio Pharma Completes Acquisition of Best Formulations
• Nemus Bioscience Announces Agreement with Pii
• Coldstream Laboratories Names Director of Formulation Development
• Experic Adds Spray Drying Capabilities to Enhance Pharmaceutical Formulation and Development Services
• Evonik Expands Its Formulation Capabilities for Lipid Nanoparticles Used For mRNA And Gene Therapies
• Formulated Solutions to Acquire FDA Approved Drug Production Site
• Aesica and EmulTech Develop Sterile Emulsion Technology for Micro Encapsulation (ET4ME)
• Curia to Acquire Integrity Bio, Expanding Its Biologic Formulation and Fill-Finish Capabilities
• JanOne Announces Formulation, Development Agreement with CoreRx
• DFE Pharma, Harro Höfliger, and Sterling Partner in “INTO” to Provide Formulation Services for Respiratory Products
• Noramco and SPI to Collaborate on Ready-to-Implement, Patient-Friendly Formulations
• Catalent Collaborates with MGB Biopharma
• Coriolis Pharma Opens New ATMP Formulation Development Facilities
• Aragen Commissions Formulations Manufacturing Facility in Hyderabad, India
• Sirio Pharma Opens Gummy Production Plant in China
• Therapix Signs Formulation Development, Manufacturing Agreement with Catalent
• Inhibrx Exercises Option to License New Formulation Developed by Arecor
• Halozyme Announces First Clinical Dosing of Pfizer's Rivipansel Using Enhanze™ Technology
• Recipharm Partners with Aptahem for Formulation of Apta-1 Drug Candidate
• JanOne Completes Formulation of JAN101 in Preparation for GMP Manufacturing Batch
• Colorcon Opens New Formulation Services Facility in Bogota, Colombia
• WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility
• Velesco Acquires Research, cGMP Analytical Laboratory
• ReForm Biologics, MilliporeSigma Announce Licensing Agreement
• Ferring and Alrise Biosystems to Develop an Injectable, Controlled-Release Peptide
• Ferring and Foresee Pharmaceuticals Enter into Exclusive Development and Option Agreement
• Altus Formulation Partners with Evonik to Manufacture SmartCelle Insoluble Drug Delivery Technology
• Formulated Solutions Completes Large Scale Expansion
• Catalent and Grünenthal Announce Successful Collaboration to Facilitate Expedited Clinical Development Timelines
• Vectura and Inspira Pharmaceuticals Sign Agreement to Develop Potential Inhaled Treatment for COVID-19
• Glucagon-like peptide-1 (GLP-1) Receptor Agonist Semaglutide in an Oleogel Formulation Using the BrainDos™ Technology Significantly Increases Drug Delivery into Cells
• Aenova Launches Program to Accelerate Pharmaceutical Development
• Capsugel to Acquire Bend Research
• Particle Sciences Expands Biopharmaceutical Development Infrastructure
• Imprimis Pharmaceuticals to Make Compounded and Customizable Formulation of Pyrimethamine and Leucovorin

• Formulation Development Roundtable
• An Interview With Adrian Raiche - Focus: Formulation Development
• The Importance of Formulation Design in Oral GLP Toxicology Studies
• Trends in Enhancing API Solubility
• Formulation Development Roundtable
• Fighting Prescription Drug Abuse With Demonstrated Abuse-deterrent Formulations
• Expedient Development of a Solid Formulation with Enhanced Pharmacokinetic Exposure for Phase I Trials
• Formulation Development Roundtable
• Utilization of Physiologically Based Pharmacokinetics Modeling in the Development of Orally Administered Formulations Intended for Systemic Delivery of Small Molecules
• An Interview With...David Lyon, Director of Research, Capsugel’s Bend, Ore. Facility

• Navigating Formulation Development: Key Questions for Pharmaceutical R&D Leaders
• Roundtable: Pediatric Dosage Forms
• Developing a New Carrier Protein for Conjugate Vaccines: Analytical Strategies for Similarity Testing and Formulation Development
• Selecting Formulations for Drug Discovery and Early Drug Development – Current Challenges and Emerging Approaches for Predicting Bioperformance
• Roundtable: Solid Dosage Trends
• The Effect of Formulation Excipients on Leachables for IV-Administered Products
• Analytical Challenges for Developing Dry Powder Inhalation Products
• Energizing Client Portfolios With Patient-friendly Dosage Forms
• Oral Solid Dosage Manufacturing
• An Interview with... Anthony Qu, PhD Vice President of Scientific Affairs, Cambrex
• Integrated CDMO and CRO Services Creates Innovation in Early-Stage Drug Development
• An Interview With Shawn Cain, Chief Operating Officer, LSNE
• A Quarterly Review of New Drug Applications – October-December 2022
• Expanding the Commercial Options for Preparation of Amorphous Solid Dispersions
• An Interview with… Anthony Qu, PhD, Cambrex
• Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients (APIs)
• An Interview With...Matthew Shaffer, Senior Researcher, Capsugel
• Formulation Development of Poorly Stable and Poorly Permeable Drugs
• Navigate Future Risks to Clinical Trial Supply
• An Interview with Dr. Uwe Hanenberg - Head of Product Development, Oral Solid Dose

Videos Search Results for "formulation"

• On-Demand Webinar: The Pitfalls and Strategies for Pediatric Formulation Development
• On-Demand Webinar: Formulating to Enable High Concentration mAb Stability
• Watch Video: Interview with Michele Luche from AMRI at AAPS 2016
• On-Demand Webinar: The Pitfalls and Strategies for Pediatric Formulation Development
• On-Demand Webinar: Novel ADC Conjugates: Characterization Tools and Formulation/Process Development
• Watch Video: Mark Egerton, CEO of Quotient Sciences, Interview at AAPS 2017
• Documentary: A Solid Dosage Future
• Watch Video: Pyramid Laboratories Facility Tour
• On-Demand Webinar: Integrated Drug Product Development – Considerations from Pre-Clinical to Commercialization
• Watch Video: Sterile and Specialty Services: from Development to Distribution with DPT Labs

• Selecting a Transfection Reagent for Large Scale Protein Production in Suspension 293 Cell Types

• Using Quality by Design (QbD) for Process Optimization of a Novel Oral Solid Dosage Form